Developing a compelling, differentiated, value proposition is crucial for optimal market access. With input from a panel of experts, Raf De Wilde, our Senior Executive Advisor, and Carolyn Steeds, Associate Director, discussed how to develop a successful payer value strategy while avoiding some of the common pitfalls that experience tells can hinder pricing and market access success. Complete the form to watch the webinar now.
- Marcus Dahlman, European Head of Market Access at Hansa Biopharma.
- Brent Fraser, Vice President of CADTH, Pharmaceutical Reviews.
- Harry Ward, Former director of Commissioning to Wolverhampton City Primary Care Trust.